phorbolol myristate acetate has been researched along with Nasopharyngeal Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JK; Chu, WK; Dai, PM; Li, HL; Pao, CC | 1 |
1 other study(ies) available for phorbolol myristate acetate and Nasopharyngeal Carcinoma
Article | Year |
---|---|
Nanog expression is negatively regulated by protein kinase C activities in human cancer cell lines.
Topics: Carcinoma; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Hep G2 Cells; Homeodomain Proteins; Humans; Isoenzymes; Mutagenesis, Site-Directed; Nanog Homeobox Protein; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Octamer Transcription Factor-3; Promoter Regions, Genetic; Protein Kinase C-alpha; Protein Kinase C-delta; RNA, Messenger; SOXB1 Transcription Factors; Tetradecanoylphorbol Acetate; Transcription, Genetic | 2013 |